Suspension of trading
Transcripts Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 24-08-13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 24-08-07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Transcripts
Search
| 23-08-08 | Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
